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A Calcium-Responsive Transcription Factor, CaRF,
that Regulates Neuronal Activity-Dependent
Expression of BDNF
BDNF was initially identified as a brain-derived survival
factor for central neurons (Leibrock et al., 1989;
Schwartz et al., 1997), but has subsequently been shown
to have a wide range of effects on both central and
peripheral neurons (Kafitz et al., 1999; Lohof et al., 1993;
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McAllister et al., 1995; Poo, 2001; Ringstedt et al., 1998;2 Department of Neurobiology and
Wang et al., 1995). In concordance with its role as an3 Program in Biological and Biomedical Sciences
effector of neuronal activity in the brain, the transcriptionHarvard Medical School
of BDNF is exquisitely sensitive to regulation by neuronalBoston, Massachusetts 02115
activity. The expression of BDNF mRNA is highly in-
duced by seizure (Zafra et al., 1990) and by stimuli used
to induce LTP in the hippocampus (Patterson et al.,Summary
1992). BDNF expression is also modulated in vivo by
endogenous synaptic activity during behaviors (CastrenTranscription of the brain-derived neurotrophic factor
et al., 1992; Liang et al., 1998; Tokuyama et al., 2000).(BDNF) gene is regulated in a calcium- and neuron-
Since the observation was first made that the tran-selective manner; however, the mechanisms that un-
scription of genes such as BDNF is regulated by neu-derlie this selectivity are not known. We have charac-
ronal activity, a number of laboratories have contributedterized a new calcium-response element, CaRE1, that
to a working model of the mechanisms that drive activ-is required for activity-dependent transcription of
ity-induced neuronal gene expression (Bito et al., 1997;BDNF exon III and have cloned a transcription factor,
Cruzalegui and Bading, 2000; West et al., 2001). Briefly,CaRF, that activates transcription from BDNF pro-
neurotransmitter reception and membrane depolariza-moter III in a CaRE1-dependent manner. The transcrip-
tion lead to the influx of calcium across the plasmational activity of CaRF is regulated in a calcium- and
membrane, initiating cascades of intracellular signalingneuron-selective manner, suggesting that CaRF may
pathways that carry the signal to the nucleus to activateconfer selectivity upon the activity-dependent induc-
transcription factors. These transcription factors bindtion of BDNF exon III expression.
to key regulatory elements within the promoter regions
of the responsive genes and recruit the basal transcrip-
Introduction tion machinery.
We have been studying the activity-dependent tran-
Neuronal activity is a driving force for the development scription of BDNF as a means to identify transcription
and function of the brain, leaving a long-lasting imprint factors that mediate activity-regulated gene expression
on both neuronal structure and function through the in neurons. The BDNF gene has a complex organization,
induction of new gene expression. Activity-regulated with four initial noncoding exons, each of which can be
gene transcription is required for the ability of membrane alternatively spliced in a tissue- and stimulus-specific
depolarization to promote neuronal survival (Ghosh et manner to a single 3 exon containing the coding se-
al., 1994; Mao et al., 1999) and for maintenance of the quence (Timmusk et al., 1993, 1995). Exon III-containing
late phases of both long-term potentiation (LTP) and transcripts are the most highly induced in response to
long-term depression (Ahn et al., 1999; Nguyen et al., elevated KCl-mediated membrane depolarization of em-
1994). The expression of a large number of genes has bryonic cortical neuron cultures (Tao et al., 1998). A
been shown to be rapidly induced by neuronal activity region of 170 bp upstream from the exon III initiation
(Lanahan and Worley, 1998; Nedivi et al., 1993). These site is sufficient to recapitulate activity-dependent tran-
genes include both transcription factors, such as c-fos scription of a reporter gene. Within this fragment, a se-
(Greenberg et al., 1986), that function in a wide variety of quence resembling the calcium/cAMP response ele-
cell types to mediate adaptive responses to extracellular ment (CRE) bound by members of the CREB family of
stimuli, as well as a second class of genes, such as transcription factors is required for activity-dependent
Narp (O’Brien et al., 1999), Homer (Tu et al., 1998), and induction of the reporter gene (Shieh et al., 1998; Tao
Cpg15 (Nedivi et al., 1998), whose expression is enriched et al., 1998). However, mutation of a distinct region up-
in the nervous system and which act to regulate synaptic stream of the CRE-like sequence also blocks activity-
function. Neuron-selective mechanisms that may regu- dependent induction of the reporter gene (Shieh et al.,
late transcription of these synaptic gene products are 1998; Tao et al., 1998). This result indicates that CREB
not well understood. alone is not sufficient to drive expression of BDNF exon
III transcription, and suggests that there must be otherOne of the most extensively studied of the neuronally
transcription factors cooperating with CREB to mediateenriched class of activity-induced genes encodes the
activity-dependent expression of BDNF exon III. A criti-neurotrophin brain-derived neurotrophic factor (BDNF).
cal unanswered question is what specific functions the
transcription factors that bind to the region 5 to the4 Correspondence: michael.greenberg@tch.harvard.edu
CRE-like sequence play in mediating activity-dependent5 These authors contributed equally to this work.
transcription of BDNF in neurons.6 Present address: Curis Incorporated, Cambridge, Massachusetts
02138. In this report, we demonstrate that the induction of
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BDNF exon III expression in neurons is selectively acti-
vated by calcium influx, but not by other stimuli such
as those that lead to the elevation of cAMP, even though
both types of stimuli lead to the activation of CREB. In
addition, we find that the induction of BDNF exon III
transcription in response to calcium influx is selectively
found in neurons, but not in the neuroendocrine cell line
PC12, although CREB is activated by calcium influx in
both cell types. These findings led us to investigate
whether transcription factors binding to the region 5 to
the CRE-like sequence in BDNF promoter III might con-
fer calcium and neural selectivity on the induction of
BDNF exon III expression. We have conducted detailed
mutagenesis of the region of BDNF promoter III 5 to
the CRE-like sequence and find that the 5 element com-
prises a binding site for two distinct transcription fac-
tors. In this study, we characterize the most distal cal-
cium-response element which we term CaRE1. We find
that CaRE1 is required for membrane depolarization-
mediated induction of a BDNF promoter III reporter gene
in neurons in a calcium- and neural-selective manner.
Using CaRE1 in a yeast one-hybrid screen, we have
cloned a CaRE1-dependent transcription factor, CaRF,
whose activity is regulated in a calcium- and neuron-
selective manner, suggesting that CaRF may confer cal-
cium and neural selectivity upon BDNF promoter III. The
identification of CaRF as a neuronal, calcium-regulated,
transcriptional activator of BDNF exon III expression
suggests that this transcription factor may play a key
role in neuronal development and plasticity.
Results
The Induction of BDNF Exon III Expression
Figure 1. The Induction of BDNF Exon III Expression Is Calcium andIs Calcium and Neuron Selective
Neuron SelectiveAs a first step toward identifying the molecular mecha-
(A) Real-time quantitative PCR was used to measure BDNF exon IIInisms that regulate transcription of BDNF exon III, we
expression levels in unstimulated 6DIV neurons or after 1, 3, or 6
investigated the range of stimuli that lead to induction hr of membrane depolarization (gray) or elevation of cAMP (black).
of BDNF exon III mRNA expression. Using a quantitative BDNF exon III levels were normalized for expression of GAPDH.
RT-PCR analysis, we find that BDNF exon III expression (B) Real-time quantitative PCR was used to measure c-fos mRNA
expression levels in unstimulated 6 DIV neurons or after 1, 3, or 6is regulated in a calcium- and neuron-selective manner.
hr of membrane depolarization (gray) or elevation of cAMP (black).In cultured rat cortical neurons, BDNF exon III mRNA
c-fos levels were normalized for expression of GAPDH.expression is induced over 100-fold by membrane depo-
(C) Real-time quantitative PCR was used to measure BDNF exon III
larization and subsequent calcium influx; however, ele- (gray) and c-fos (black) expression levels in undifferentiated PC12
vation of intracellular cAMP levels leads to little if any cells left unstimulated or after 1, 3, or 6 hr of membrane depolariza-
induction of BDNF exon III (Figure 1A). By contrast, both tion. BDNF and c-fos levels were normalized for expression of
GAPDH.stimuli drive similar increases in the expression of c-fos
(Figure 1B). Regulation of BDNF exon III expression was
found to be cell type selective, with induction occurring is consistent with the previous observation that deletion
in neurons, but not in several other cell types. For exam- of a region 5 to the CRE-like sequence in BDNF pro-
ple, in the neuroendocrine-like pheochromocytoma cell moter III blocks induction of expression of a BDNF pro-
line PC12, membrane depolarization failed to stimulate moter III reporter gene (Shieh et al., 1998; Tao et al.,
transcription of BDNF exon III (Figure 1C), despite the 1998), suggesting that transcription from BDNF pro-
fact that PC12 cells express functional L-type voltage- moter III may require the coordinate activation of several
sensitive calcium channels (L-VSCCs; Greenberg et al., transcription factors. We therefore considered the pos-
1986) and show rapid induction of c-fos (Figure 1C). sibility that the element(s) 5 to the CRE-like sequence
These data demonstrate that the induction of BDNF and the transcription factors that bind to these elements
exon III transcription is restricted to a limited range of might confer calcium and neural selectivity upon the
cell types and stimuli. Notably, although BDNF expres- induction of BDNF exon III transcription.
sion is regulated in part by the transcription factor CREB,
the range of stimuli that lead to induction of BDNF exon Characterization of CaRE1, a Calcium-Response
III expression is more limited than the range of stimuli Element in BDNF Promoter III
that lead to the activation of CREB, indicating that CREB Previously we found that 170 bp of the 5 flanking se-
quence of BDNF exon III is sufficient to drive transcrip-is not sufficient to drive BDNF expression. This finding
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tion of a transfected reporter gene in response to mem- and subsequent calcium influx, the ability of this element
brane depolarization of cultured embryonic cortical to function independently of other CaREs from the BDNF
neurons (Tao et al., 1998). Induction of this promoter is promoter suggests that the calcium responsiveness of
driven by the depolarization-induced influx of calcium the element may be conferred by direct calcium signal-
through L-VSCCs and the activation of downstream cal- ing pathway-dependent regulation of the transcription
cium-responsive signaling pathways. To identify the factor(s) that binds to CaRE1.
transcription factors that drive BDNF exon III expres- We have hypothesized that the activation of transcrip-
sion, we have mapped their presumptive binding sites tion factors binding to the elements upstream of the
by using deletion analysis and mutagenesis to iden- CRE/CaRE3 sequence may confer calcium and neuron
tify calcium-responsive enhancer elements contained selectivity upon the induction of BDNF promoter III. Con-
within the 170 bp of BDNF promoter III. Deletion of the sistent with this hypothesis, elevation of cAMP does not
sequence between nucleotides84 and43 bp relative lead to an induction of CaRE1-dependent transcription
to the initiation site of BDNF exon III or 6 bp substitution when the reporter is expressed in cortical neurons (Fig-
of the sequence between nucleotides77 and60 elim- ure 2D). The induction of CaRE1-dependent transcrip-
inated induction of the BDNF promoter III reporter in tion is also selective for neurons, as the reporter is not
transfected neurons, suggesting that this region of the activated by membrane depolarization of PC12 cells
promoter contains a critical calcium-response element (Figure 2E). These data indicate that CaRE1-dependent
(Tao et al., 1998). transcription is activated in a calcium- and neuron-
To define calcium-response elements within this re- selective manner.
gion, we made two base pair substitutions of the DNA
sequence that lies between nucleotides 77 and 60 CaRF Is a CaRE1 Binding Protein
in BDNF promoter III. Mutations were introduced by PCR To determine if there are neuronal nuclear proteins that
into the pIII(170)Luc BDNF promoter reporter plasmid, bind CaRE1 and thereby mediate the calcium-respon-
which contains 170 bp of BDNF exon III 5 flanking se- sive induction of BDNF transcription through this ele-
quence and exon III fused to the coding region of the ment, we performed electrophoretic mobility shift
firefly luciferase gene. When transiently transfected into assays (EMSAs) with a radiolabeled 25 bp fragment of
cortical neurons, membrane depolarization strongly en- DNA corresponding to the BDNF promoter region con-
hanced the expression of luciferase from plasmids con- taining the CaRE1 element. When nuclear extract from
taining the wild-type sequence (Figure 2A). Most muta- E18 rat brain cortex was incubated with the DNA probe,
tions between nucleotides 73 and 64 significantly one major complex was identified (Figure 3A). An equiva-
reduced the magnitude of luciferase induction relative lent shift was seen from nuclear extracts prepared from
to wild-type levels, while mutations between nucleotides unstimulated neurons, or neurons depolarized for 1, 2,
77 and74 or63 and60 had no effect. These data or 3 hr, suggesting that depolarization does not directly
identify a 10 bp calcium-response element spanning the regulate protein binding to CaRE1 or the nuclear local-
sequence between nucleotides 73 and 64 in BDNF ization of the CaRE1 binding protein (Figure 3B). The
promoter III that we have named calcium response ele-
binding of this protein(s) to CaRE1 was specific, as for-
ment 1 (CaRE1). The CaRE1 sequence is conserved in
mation of the complex was competed by the addition
the rat, human, and mouse BDNF genes. A search of
of an excess of an unlabeled DNA fragment with the
the TRANSFAC database (http://www.cbil.upenn.edu/
wild-type CaRE1 sequence, but not by the addition of
tess/index.html) revealed that the sequence of CaRE1
unlabeled fragments in which the CaRE1 element was(5-CTATTTCGAG-3) does not match the binding site
mutated to sequences that do not support a calciumsequence for any known transcription factor, suggesting
response in the context of the BDNF pIII(170)Luc re-that this element may bind to a novel transcription
porter (from Figure 2A). This correlation between thefactor(s).
binding of the nuclear factor to CaRE1 sequences andMutagenesis of the region between CaRE1 and the
the ability of these sequences to support calcium induc-CRE-like sequence in BDNF promoter III has revealed
tion of the BDNF pIII(170)Luc reporter suggests that thethe presence of a third CaRE, which we have termed
nuclear protein(s) that binds to CaRE1 is the endoge-CaRE2 (W.G. Chen et al., submitted). Figure 2B shows
nous protein(s) that regulates calcium-dependent tran-a diagram of the position of these three CaREs with
scription through CaRE1 in membrane-depolarizedrespect to each other and the BDNF exon III transcrip-
neurons.tional initiation site.
Because the sequence of CaRE1 does not resembleHaving found that CaRE1 is necessary for membrane
a known transcription factor binding site, we used adepolarization-mediated induction of BDNF promoter
yeast one-hybrid screen to clone CaRE1 binding pro-III, we next sought to determine if this element is suffi-
teins. Three independent clones were isolated from thecient to mediate a transcriptional response to membrane
screen; however, extracts from only one of these clonesdepolarization. To measure the activity of CaRE1, we
contained a protein that specifically bound CaRE1 byisolated it from other elements in BDNF promoter III.
EMSA (Figure 3C). Sequencing of this clone revealedThree copies of the CaRE1 sequence were cloned into
that it is a novel protein that we have named CaRF forthe pGL3 vector immediately 5 to a minimal promoter
calcium response factor (Figure 3D). Human, murine,driving expression of the firefly luciferase gene. Mem-
bovine, and porcine ESTs with homology to this se-brane depolarization of neurons transfected with this
quence have been deposited in GenBank; however, weconstruct led to a significant induction of luciferase ex-
identified no homologs in Drosophila or C. elegans. Thepression (Figure 2C; p  0.0001). In addition to demon-
human CaRF cDNA is 3.1 kb and codes for a protein ofstrating that the CaRE1 element is sufficient to mediate
a transcriptional response to membrane depolarization 725 amino acids. The mouse sequence was obtained
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Figure 2. CaRE1 Is a Calcium-Response Ele-
ment in BDNF Promoter III
(A) A BDNF promoter III luciferase reporter
plasmid with wild-type or mutant sequences
was transfected into E18  3DIV rat cortical
neurons. Two days after transfection, neu-
rons were left unstimulated or stimulated for
9 hr with 50 mM KCl, then homogenized and
assayed for luciferase and -galactosidase
expression from cotransfected pEF-lacZ.
Fold induction is defined as the ratio of -gal
normalized luciferase from stimulated cells
relative to the normalized luciferase from un-
stimulated cells. The gray box indicates the
region of BDNF promoter III that corresponds
to CaRE1.
(B) Diagram of the three CaREs in BDNF pro-
moter III is shown. The arrow indicates the
transcriptional start site for BDNF exon III,
and all numbering is relative to this site.
(C) Neurons transfected with either the empty
pGL3 vector or the CaRE1-luciferase plasmid
were either left unstimulated (gray) or depo-
larized with 50 mM KCl for 9 hr (black), then
harvested for luciferase assay. Values are
normalized for cotransfected renilla lucifer-
ase. The data presented is the average of at
least three measurements from each of three
independent experiments. Asterisk (*) indi-
cates a significant increase in luciferase ex-
pression (p  0.0001).
(D) The BDNF pIII(170)Luc, CaRE1-luciferase,
and CRE-luciferase plasmids were trans-
fected into cortical neurons. Two days later,
these cells were either left unstimulated (gray)
or stimulated with 300 M each CPT-cAMP
and IBMX for 9 hr (black), then lysates were
processed for luciferase assays. Values are
normalized for cotransfected renilla lucif-
erase.
(E) The BDNF pIII(170)Luc, CaRE1-luciferase,
and CRE-luciferase plasmids were trans-
fected into PC12 cells. Two days later, these
cells were either left unstimulated (gray) or
stimulated with 50 mM KCl for 7 hr (black),
then lysates were processed for luciferase
assays. Values are normalized for cotrans-
fected renilla luciferase.
by hybridization of a human CaRF probe to a P0 mouse of chromosome 2q33. Multiple splice variants of CaRF
were identified by RACE, RT-PCR, and databasebrain lambda phage library, and is 71% identical overall
(80% conserved). A fragment of CaRF encoding amino searches, including two C-terminally truncated forms of
CaRF that use alternative polyadenylation sites withinacids 144–725 was recovered from the yeast one-hybrid
screen. RACE was used to identify the 5 and 3 ends introns (Figure 3D).
Extensive analysis of the CaRF sequence has shownof both the mouse and human clones. The 5 end of each
clone contains multiple stop codons in all three frames that it has no significant homology to any known proteins
in the GenBank database and no domains that wouldupstream of the triplet codon that encodes the first methio-
nine, suggesting that we have identified the 5 end of the identify it as a member of a family of transcription fac-
tors. However, consistent with its role as a putative tran-CaRF coding sequence. In addition, the start methionine
of the CaRF cDNA lies within a Kozak consensus se- scriptional regulator of BDNF exon III expression, the
CaRF sequence contains a predicted nuclear localiza-quence. Alignment with the Celera and NIH human ge-
nome databases revealed that the CaRF coding se- tion signal (NLS; Figure 3D), two glutamine-rich helices
which are found in many transcriptional activators (Trie-quence is composed of 14 exons spanning about 50 kb
CaRF: A Calcium-Regulated Transcription Factor
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Figure 3. CaRF Is a CaRE1 Binding Protein
(A) Nuclear extracts from cortical neurons were mixed with a radiolabeled CaRE1 probe, then subjected to EMSA. Association of a nuclear
protein with CaRE1 (black arrow) causes a retardation in the migration of the labeled probe (arrowhead). This binding can be competed by
addition of an excess of unlabeled wild-type probe, but not by addition of an excess of unlabeled CaRE1 probes containing mutations that
block the function of CaRE1 in the reporter gene assay shown in Figure 2A (M1-4). The mutant sequences used were: M1-CTtccgCcAG, M2-CTA
TTTCGcttagc, M3-CTATTTCGcG, M4-CTATTTtaAG (the CaRE1 sequence is underlined). A nonspecific band is marked by the asterisk (*).
(B) Cultured cortical neurons were depolarized with 50 mM KCl for 0, 1, 2, or 3 hr, before nuclear extracts were harvested and subjected to
EMSA with the CaRE1 probe. The arrow shows the retarded protein-DNA complex and the arrowhead marks the unbound probe.
(C) Nuclear extracts from yeast or yeast overexpressing CaRF were assayed by EMSA for binding to radiolabeled CaRE1. In labeled lanes,
an excess of unlabeled wild-type or mutant (M1-4) CaRE1 probe was added to test for competition of binding to CaRE1. The mutant sequences
used are the same as those for Figure 3A. The arrow marks the CaRE1-CaRF complex. The asterisk (*) marks a nonspecific retarded band
not competed by addition of wild-type unlabeled probe.
(D) shows sequence of mouse (M) and human (H) CaRF. Identical amino acids are indicated by asterisks, conserved amino acids by dots.
Gaps are indicated by dashes. The predicted NLS is highlighted in bold. Stars above the sequence indicate the location of two alternative
polyadenylation signals that lead to early truncations. GenBank accession numbers are AF454946 (human) and AF454947 (mouse).
zenberg, 1995), and consensus phosphorylation sites against recombinant CaRF recognize the endogenous
CaRE1 binding protein in nuclear extracts? (3) Is CaRFfor a number of kinases including calcium-calmodulin
kinase II, mitogen-activated protein kinase, and protein expressed in the nuclei of neurons that show activity-
dependent expression of BDNF exon III? (4) Does CaRFkinase C.
Given the novelty of the CaRF sequence, we estab- act as a CaRE1-dependent transcriptional activator?
lished a set of criteria to determine if CaRF is a bone
fide transcription factor capable of supporting calcium- CaRF Is a Neuronal CaRE1-Dependent
Transcriptional Activatorresponsive induction of BDNF exon III transcription. To
this end, we asked the following questions: (1) Will CaRF If CaRF is a regulator of activity-dependent BDNF ex-
pression through CaRE1, CaRF might be expected tobind selectively to CaRE sequences that support cal-
cium-dependent induction in the context of the BDNF bind to wild-type CaRE1 sequences, but not to se-
quences that fail to support calcium-dependent induc-pIII(170)Luc reporter gene? (2) Will an antibody raised
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tion in the context of the BDNF pIII(170)Luc reporter
gene. CaRF binds a radiolabeled CaRE1 fragment by
EMSA and this binding is competed by addition of ex-
cess wild-type unlabeled CaRE1 probe (Figure 3C).
However, formation of the CaRE1-CaRF complex is not
competed by addition of a panel of mutant CaRE1 se-
quences that do not support the depolarization-medi-
ated induction of the BDNF pIII(170)Luc reporter plasmid
(Figure 3C). This correlation between the binding of
CaRF to CaRE1 sequences and the ability of these se-
quences to support calcium-dependent transcription
from BDNF pIII(170)Luc suggests that CaRF is identical
or closely related to the protein from neuronal nuclear
extracts that binds CaRE1 and contributes to the regula-
tion of BDNF exon III transcription.
To further test the possibility that CaRF is the CaRE1
binding protein in neuronal nuclear extracts, we raised
antibodies against recombinant CaRF and asked if the
antibodies could alter the CaRE1-neuronal nuclear pro-
tein complex seen by EMSA. Preincubation of neuronal
nuclear extracts with the anti-CaRF serum blocked for-
mation of the CaRE1 complex (Figure 4A). By contrast,
incubation with preimmune serum from the same rabbit
had no effect, and addition of the antibodies to the
CaRE1 fragment in the absence of added nuclear extract
had no effect on the CaRE1 fragment. These data indi-
cate that the endogenous CaRE1 binding protein from
neuronal nuclear extracts is either CaRF or a protein
immunologically related to CaRF.
Using the antibodies raised against recombinant hu-
man CaRF, we further assessed the subcellular localiza-
tion of endogenous CaRF in rat neurons. These antibod-
ies recognize recombinant human CaRF by Western blot
analysis, though rather than the predicted molecular
weight of 80 kDa, the protein migrates at 96 kDa when
synthesized by in vitro transcription and translation or
when overexpressed in HEK-293T cells (Figures 4B, 4C,
and 6C). As predicted from the rodent amino acid se-
quence, rat CaRF is slightly smaller (94 kDa) than the
Figure 4. CaRF Is a Neuronal Nuclear Proteinhuman form. This 94 kDa band is not recognized by
(A) Nuclear extracts from cortical neurons were incubated with ra-preimmune serum from the same rabbit used to raise
diolabeled CaRE1 probe in the presence or absence of preimmunethe anti-CaRF antibody, and recognition of the band is
or anti-CaRF serum. The arrowhead indicates the unbound labeledfully competed by preincubation of the antibody with
probe. The arrow marks a band retarded by addition of cortical
recombinant GST-CaRF, but not by preincubation of the neuron nuclear extract or recombinant CaRF which is eliminated by
antibody with recombinant GST (Figure 4C). Consistent preincubation of the extract or recombinant protein with anti-CaRF
with the presence of a putative NLS in the CaRF se- serum but not preimmune serum. No shift of the probe is seen when
sera are added to the CaRE1 probe alone.quence, we found that rat CaRF is highly enriched in
(B) Nuclear extracts were prepared from E18 5DIV cortical neuronsnuclear extracts from cultured rat cortical neurons as
in culture. Equal protein from either the cytoplasmic (cyto.) or thecompared to the cytoplasmic fraction (Figure 4B). The
nuclear fraction (NE) was loaded on an 8% SDS-PAGE gel, trans-band detected at 55 kDa in the cytoplasmic fraction may
ferred, and reacted with an antibody raised against recombinant
reflect expression of one of the C-terminally truncated CaRF. The arrowhead indicates a band of approximately 94 kDa
forms of CaRF, as the shortest predicted form lacks the that is highly enriched in neuronal nuclei.
putative NLS (Figure 4B). The function of this truncated (C) Nuclear extracts (NE) or in vitro transcribed and translated CaRF
(TNT) were studied by Western analysis. The arrowheads mark theform of CaRF is unknown.
96 kDa molecular weight marker. Blots were probed with anti-CaRFFor CaRF to be a regulator of BDNF expression, it
serum, preimmune serum, or anti-CaRF serum that had been prein-should be expressed in neurons that show activity-
cubated for 1 hr with recombinant GST or recombinant GST-CaRF.dependent induction of BDNF exon III transcription. We
first characterized the tissue distribution of CaRF by
Northern analysis of multiple adult mouse tissues (Figure
expressed in testis. The expression of CaRF in tissues5A). A 5 kb band reacting with the CaRF probe was
outside of the nervous system suggests that CaRF maydetected at low levels in several tissues but at a high
have important biological functions in addition to its rolelevel in brain, a pattern consistent with a role for CaRF
in the activity-dependent regulation of BDNF expres-in the regulation of BDNF exon III transcription (Timmusk
et al., 1993). A smaller 3 kb transcript was also highly sion. To determine which cells in the brain express
CaRF: A Calcium-Regulated Transcription Factor
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Figure 5. Pattern of CaRF Expression
(A) A mouse tissue Northern blot containing 1 g polyA RNA per lane was probed with a radiolabeled RNA probe containing the CaRF open
reading frame. All tissues except embryo were taken from adult mouse. After the CaRF probe decayed, the blot was reprobed for GAPDH to
compare total RNA loading per lane.
(B) Brains of mice at P4 or adult were fixed and sunk in sucrose, then coronal cryostat sections were prepared and hybridized with an antisense
33P labeled RNA probe representing the full CaRF cDNA. The bar indicates 1 mM.
(C) E19 hippocampal cultures were grown for 5DIV, then fixed and stained with the anti-CaRF antibody (red) and an antibody against the
neuronal marker -tubulin III or the glial marker GFAP (both in green). Nuclei are labeled with Hoechst dye in blue. Overlap of CaRF with
nuclei is indicated by the pink color. The bar indicates 30 m.
(D) Nuclear extracts were made from rat brains at E19, P0, P6, P9, and adult. Equal amounts of protein were loaded into each lane and
separated by SDS-PAGE electrophoresis. The gel was transferred and probed with the anti-CaRF antibody. The arrow marks the 96 kDa
molecular weight marker.
CaRF, we performed in situ hybridization of mouse brain throughout development and into adulthood (Figure 5D),
consistent with the temporal pattern of BDNF exon IIIsections. The highest levels of CaRF expression were
found in the hippocampus of developing and adult expression in brain (Timmusk et al., 1994).
A feature of transcription factors is that they oftenmouse, with lower levels of diffuse expression through-
out the cortex, areas where activity-dependent tran- have modular DNA binding and transcriptional activa-
tion domains. To determine if there is a specific regionscription of BDNF exon III containing transcripts occurs
(Figure 5B). Lower levels of CaRF mRNA were detected of CaRF that mediates binding to CaRE1, we assessed
the ability of in vitro transcribed and translated N- andin the granule cells of the adult cerebellum. To determine
if the expression of CaRF in the brain is restricted to C-terminally truncated versions of CaRF to bind to
CaRE1 by EMSA. Deletion of the first 144 amino acidsneurons, we used the anti-CaRF antibody to assay for
endogenous CaRF in the nuclei of cultured hippocampal from the N terminus had no effect on binding to CaRE1;
however, a deletion removing the N-terminal 226 aminoneurons and astroglial cells. CaRF was detected in the
nuclei of cells expressing the neuronal marker protein acids or an internal deletion of amino acids 187–277
completely abolished the ability of CaRF to bind CaRE1-tubulin III, but not in the nuclei of cells reactive for the
astroglial lineage marker GFAP (Figure 5C). No nuclear (Figure 6A). By contrast, deletion of the C-terminal 126
amino acids had no effect on DNA binding. All truncatedstaining was seen when cells were incubated with preim-
mune serum from the same rabbit (data not shown). constructs and the wild-type CaRF protein were ex-
pressed at similar levels as judged by Western analysisFinally, Western analysis of nuclear extracts made from
rat brain revealed that CaRF is expressed in nuclei (data not shown). These data suggest that the DNA bind-
Neuron
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Figure 6. DNA Binding and Transcriptional Activation Domains of CaRF
(A) N- and C-terminally truncated or internally deleted CaRF constructs were transcribed and translated in vitro, then assayed for binding to
radiolabeled CaRE1 by EMSA. The specificity of binding was assessed by competition with wild-type unlabeled CaRE1. The arrow marks the
CaRE1-CaRF complex, the arrowhead points to the unbound probe.
(B) The CaRE1 reporter was transfected into 293T cells along with either full-length CaRF, a truncated CaRF lacking the C-terminal 126 amino
acids (CaRF 1-599), or the pEF vector. A renilla luciferase plasmid was cotransfected as a control for transfection efficiency and sample
handling. Two days later, the cells were homogenized and processed for renilla and firefly luciferase.
(C) Nuclear extracts were made from 293T cells transfected at the same time as cells used for the luciferase analysis in (Figure 6B), then
analyzed by Western blot with an anti-CaRF antibody.
(D) 293T cells were transfected with the BDNF promoter reporter plasmid (pIII(170) Luc) or with a BDNF reporter that has the CaRE1 site
mutated to a sequence (CTtccgCcAG) that does not bind CaRF (mCaRE1-pIII(170) Luc). Full-length CaRF (black) or the pEFmyc-his vector
(gray), as well as TK-renilla luciferase, were cotransfected, and two days later the cells were homogenized and analyzed for renilla and firefly
luciferase.
ing domain is located in the N-terminal half of CaRF, drive transcription from the reporter plasmid. Deletion
of the C-terminal 126 amino acids of CaRF completelyand requires the region between amino acids 187 and
277. As this region shares no significant homology with abolishes the ability of CaRF to drive transcription, even
though the full-length and C-terminally deleted CaRFthe DNA binding domains of other known transcription
factors, we speculate that the DNA binding domain of constructs are expressed at similar levels in HEK-293T
cell nuclear extracts (Figures 6B and 6C). Although the CCaRF may function in a novel manner.
We next asked if CaRF when bound to CaRE1 can terminus of CaRF does not resemble any characterized
transcriptional activation domain, these experiments in-activate or repress transcription. To assay the basal
transcriptional activity of CaRF, we assessed the ability dicate that this discrete region of CaRF is required for
transcriptional activation and raise the possibility thatof transfected CaRF to drive expression of reporter
genes cotransfected into HEK-293T cells, as these cells further studies may show that CaRF functions in a novel
manner to promote transcription.contain no detectable endogenous CaRF by Western
or Northern analysis (Figure 6C and data not shown). In summary, these data demonstrate that CaRF is a
neuronal nuclear protein with discrete DNA binding andCoexpression of CaRF with the CaRE1-luciferase re-
porter or with the BDNF pIII(170)Luc reporter led to a transcriptional activation domains that can activate
transcription from the CaRE1 element in BDNF promotersignificant enhancement of luciferase expression over
that seen in cells transfected with the reporter genes III. CaRF therefore fulfills all of the criteria required to
be a bone fide transcriptional regulator of BDNF exon IIIalone (Figures 6B and 6D). Although we did detect basal
transcription activity of overexpressed CaRF in these expression, suggesting that CaRF itself is an important
mediator of activity-dependent BDNF exon III tran-cells, notably we saw no induction of CaRF activation
in response to ionomycin-mediated elevation of intracel- scription.
lular calcium levels (data not shown), consistent with
the idea that the induction of CaRF activity requires a cell The Transcriptional Activity of CaRF Is Regulated
in a Calcium- and Neuron-Selective Mannertype-specific regulatory event. Mutation of the CaRE1
element to a sequence that does not support calcium Given that the induction of both BDNF exon III expres-
sion and CaRE1-dependent transcription are calcium-induction of BDNF in neurons, or the binding of CaRF
by EMSA, blocks the ability of overexpressed CaRF to and neuron-selective, and since CaRF binds to CaRE1,
CaRF: A Calcium-Regulated Transcription Factor
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Figure 7. CaRF Is a Calcium-Regulated Transcriptional Activator in Neurons
(A) A Gal4-CaRF fusion protein was cotransfected into E18  4DIV rat cortical neurons with a Gal4-UAS reporter gene. TK-renilla luciferase
was transfected as a control for transfection efficiency and sample handling. After two days, the neurons were either left unstimulated (gray)
or stimulated for 6 hr with 50 mM KCl (black), either in the presence of the L-VSCC blocker Nimodipine, or with an equal dilution of the
nimodipine vehicle EtOH. The cells were then lysed and processed by luciferase assay. Asterisk (*) indicates a significant increase in luciferase
expression (p  0.0001).
(B) Neurons were transfected with either Gal4only, Gal4CaRF, or Gal4CREB along with the Gal4UAS reporter gene and renilla luciferase. Two
days later, the cells were left unstimulated (gray) or exposed to 300 M each CPT-cAMP and IBMX for 9 hr (black). The cells were then
harvested and processed by luciferase assay.
(C) Neurons were transfected with either Gal4CaRF or Gal4CREB along with the Gal4UAS reporter gene and renilla luciferase. Two days later,
the control cells were depolarized as for Figure 7A (gray) while another set was depolarized in the presence of 10 M H89 (black). The fold
induction of the control cells is graphed as 100%.
(D) PC12 cells were transfected with either Gal4only, Gal4CaRF, or Gal4CREB along with the Gal4UAS reporter gene and renilla luciferase.
Two days later, the cells were left unstimulated (gray) or depolarized for 7 hr (black). The cells were then harvested and processed for luciferase
assay.
we investigated the possibility that the calcium and neu- We next asked if the transcriptional activity of CaRF
is regulated in a calcium- and neuron-selective manner,ral selectivity of BDNF promoter III might be mediated
by CaRF. To first determine in neurons if CaRF activity consistent with the neuron-selective calcium activation
of BDNF exon III transcription. We found that elevationis regulated by calcium influx into neurons, we isolated
the C-terminal half of CaRF, containing the transcriptional of cAMP is not sufficient to drive Gal4 CaRF activity in
neurons, although this stimulus activates the transcrip-activation domain, by tethering it to the DNA binding do-
main of Gal4. This fusion protein was cotransfected into tional activity of a Gal4CREB fusion protein (Figure 7B).
This result demonstrates that elevation of cAMP is notneurons along with a reporter gene containing firefly luci-
ferase gene under control of a minimal promoter en- sufficient to drive CaRF activation, but since calcium
influx can lead to activation of protein kinase A (PKA)hanced by tandem copies of the Gal4 UAS element.
When transfected neurons were membrane depolarized, through the action of calcium-sensitive adenylate cy-
clases, we also asked if PKA is required for the regula-Gal4 CaRF drove a significant increase in luciferase ex-
pression (Figure 7A, p  0.0001). This increase was tion of CaRF in response to membrane depolarization.
Inhibition of PKA during membrane depolarization sig-blocked when the neurons were depolarized in the pres-
ence of the L-VSCC blocker Nimodipine, indicating that nificantly depressed the induction of Gal4CREB activity,
but had no effect on the induction of Gal4CaRF-depen-depolarization-induced calcium entry through L-VSCCs
is required for CaRF activation. No increase in luciferase dent transcription (Figure 7C). These data indicate that,
unlike the situation for CREB, the calcium-dependentexpression was seen in response to membrane depolar-
ization when only the Gal4 DNA binding domain was activation of CaRF is independent of the activation of
PKA. Finally, to ask if the activity of CaRF is regulatedexpressed with the UAS-luciferase reporter, indicating
that the transcriptional activation domain of CaRF was in a neuron-selective manner, we studied the transcrip-
tional activity of Gal4CaRF in PC12 cells. In support ofrequired for the induction of luciferase expression.
These data suggest that the transcriptional activity of selectivity, we found that Gal4CaRF is not activated by
membrane depolarization of PC12 cells although thisCaRF is induced in response to calcium influx in neu-
rons, consistent with the hypothesis that CaRF drives stimulus robustly activates Gal4CREB-dependent tran-
scription (Figure 7D).the calcium-dependent regulation of BDNF.
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From the data in total, we conclude that CaRF is a ways are mediating the effects of membrane depolariza-
tion on CaRF activity remains to be determined.novel transcriptional activator that functionally mediates
the calcium- and neuron-selective induction of BDNF If kinases regulate the transcriptional activity of CaRF,
they may do so by phosphorylating CaRF directly. Theexon III transcription.
CaRF sequence contains consensus phosphorylation
sites for CaMKII and MAP kinase, and preliminary two-
Discussion dimensional isoelectric focusing of neuronal nuclear ex-
tracts indicates that CaRF focuses in several discrete
We have cloned and characterized an activity-regulated spots, consistent with the idea that CaRF is posttransla-
transcription factor, CaRF, that functionally regulates tionally modified by phosphorylation (data not shown).
neuronal calcium-dependent expression of BDNF exon Phosphorylation of CaRF could act to enhance its bind-
III. Several lines of evidence support the hypothesis that ing to a transcriptional coactivator, or phosphorylation
CaRF is an endogenous regulator of BDNF expression. of a coactivator could alter its ability to bind CaRF.
CaRF binds to a 10 bp calcium-response element, Alternatively, phosphorylation could release binding of
CaRE1, that is required for the depolarization-mediated a transcriptional repressor, a mechanism shown to con-
induction of a BDNF promoter III reporter gene in cul- tribute to the calcium-dependent regulation of the tran-
tured embryonic cortical neurons. CaRF binds to wild- scription factor MEF2 (Youn et al., 1999). The identity
type CaRE1 sequences, but not to mutant sequences of CaRF binding proteins remains to be determined, but
that do not support activity-dependent expression of preliminary experiments indicate that CaRF does not
BDNF. An antibody raised against recombinant CaRF interact with CBP. Significant clues to the mechanism
recognizes the protein from neuronal nuclear extracts of CaRF activation may be found in a comparison of
that binds CaRE1, blocking formation of the CaRE1 neurons and PC12 cells. Though PC12 cells express
complex. CaRF expression is enriched in neuronal nuclei CaRF as detected by both Northern and Western analy-
within the cerebral cortex and hippocampus, brain re- sis (data not shown), CaRF-dependent transcription in
gions that show robust activity-induced BDNF exon III these cells is not activated by calcium influx. Whether
expression. CaRF is a CaRE1-dependent activator of PC12 cells lack the signaling pathways required for acti-
transcription, and its role as a transcriptional activator vation of CaRF or the expression of a transcriptional
is promoted by calcium influx in neurons. Finally, we coactivator, these cells will provide a convenient system
have shown that like BDNF exon III transcription, the for reconstituting the activation of CaRF-dependent
regulation of CaRF as a transcriptional activator is both transcription.
calcium and neuron selective, suggesting that CaRF
may confer calcium and neuron selectivity upon the
Transcriptional Integration Contributesinduction of BDNF exon III expression.
to Calcium Specificity of Gene Induction
Previously, we and others demonstrated that the activ-
ity-regulated transcription factor CREB is necessary butCalcium Signaling Pathways Regulate
the Activity of CaRF not sufficient for the expression of BDNF exon III, and
suggested that CREB cooperates with factor(s) bindingAlthough we have demonstrated that the transcriptional
activity of CaRF is regulated by calcium influx in neu- CaREs upstream of the CaRE3/CRE to drive expression
(Shieh et al., 1998; Tao et al., 1998). Consistent withrons, the mechanism of this activation remains to be
determined. Because CaRE1 when placed upstream of this hypothesis, CaRE1, though sufficient to mediate a
calcium response when isolated from the BDNF pro-a heterologous promoter is sufficient to mediate a tran-
scriptional response to membrane depolarization, one moter, in its native context cooperates with other ele-
ments including the CaRE3/CRE. In addition, in a sepa-potential mechanism of activation is that calcium signal-
ing pathways induce a posttranslational modification of rate study (W.G. Chen et al., submitted), we have
identified a third calcium-response element in BDNFeither CaRF or a critical CaRF-interacting protein in a
manner that promotes transcription. We did not detect promoter III, CaRE2, that lies between CaRE1 and the
CaRE3/CRE. As is seen for CaRE1 and the CaRE3/CRE,depolarization-mediated changes in the nuclear tar-
geting of CaRF or the binding of CaRF to CaRE1 (Figure mutation of CaRE2 also blocks induction of the BDNF
promoter III reporter gene. Thus, coordination of the3B and data not shown), but a remaining possibility is
that a posttranslational modification of CaRF or a critical activity of transcription factors bound at all three ele-
ments is minimally required for expression of BDNF exonCaRF-interacting protein directly promotes transcrip-
tion. This scenario is similar to the activation of CREB, III in cultured embryonic cortical neurons.
Why should three calcium-responsive elements bein which phosphorylation at Ser133 of CREB promotes
the recruitment of the transcriptional coactivator CBP required to drive induction of BDNF promoter III? The
data we have presented suggest that calcium signaling(Shaywitz and Greenberg, 1999). Several kinase cas-
cades are known to be activated by calcium influx in specificity may arise from the coordinated action of
complexes of transcription factors that form on the pro-neurons, including the calcium-calmodulin-activated ki-
nases (CaMKs), PKA, and the mitogen-activated protein moters of calcium-inducible genes such as BDNF. Sev-
eral studies have shown that not all intracellular calciumkinase (MAP kinase), and all three pathways are known
to lead to the phosphorylation of CREB at Ser133 (Impey rises lead to equivalent activation of downstream gene
expression (Bading et al., 1993; Ghosh et al., 1994).et al., 1998; Shaywitz and Greenberg, 1999). Our data
indicate that PKA is neither required nor sufficient for Cooperativity between CaRF and other calcium-regu-
lated transcription factors, such as CREB, could be athe activation of CaRF; however, which signaling path-
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pEFmyc-his (Invitrogen) for expression. Gal4CaRF was cloned bygeneral mechanism for determining the specificity of
PCR with primers against bases 951 to 2352, generating a fragmentgene induction in response to calcium influx. Different
of CaRF expressing amino acids 325–725. This CaRF fragment wasgenes may be more or less broadly inducible depending
fused in frame to the C terminus of amino acids 1–147 of Gal4 under
on the number of enhancer elements they require for control of the EF promoter in the vector pEF-Bos.
the response of the promoter, in combination with the
stimulus and cell type selectivity of the elements. One
Cell Culture, Transfection, and Stimulation
outstanding question regarding the three elements in Cortical neurons from E18 Long Evans rats (Charles River) were
BDNF promoter III is the mechanism of cooperativity cultured as described (Tao et al., 1998). Neurons were transfected at
between the three factors. Cooperativity could poten- 3-4DIV by calcium phosphate precipitation (Xia et al., 1996). Neurons
were depolarized 2 days after transfection with 50 mM KCl (Tao ettially arise from cooperatively assisted DNA binding,
al., 1998). CPT-cAMP (Sigma) and IBMX (Sigma) were added atregulated changes in genomic DNA accessibility, pro-
concentrations of 300 M each. Cells were stimulated for 1, 3, or 6tein-protein interactions between the transcription fac-
hr for quantitative RT-PCR of endogenous gene expression, and for
tors, or association with a common transcriptional co- 6–9 hr for luciferase assays. L-VSCCs were blocked by the addition
activator. of 5 M Nimodipine (Roche Molecular Biochemicals) and PKA was
blocked by addition of 10 M H89 (Calbiochem) for 5 min prior to
depolarization. PC12 cells were transfected with LipofectamineRegulation of Calcium- and Neural-Selective
2000 and stimulated 2 days later as for the neurons.Transcription by CaRF
The identification of CaRF as a neuronal calcium-depen-
Luciferase Assaysdent transcriptional activator has implications for fur-
Luciferase assays were carried out 2 days after transfection usingthering the understanding of adaptive gene transcription
the Dual Assay Luciferase kit (Promega). Cotransfected EF--gal orin neurons. Unlike many of the other calcium-regulated
TK-renilla luciferase was used to normalize samples for transfection
transcription factors known to be important for inducible efficiency and sample handling. The calcium-mediated induction of
gene expression in neurons, such as CREB, MEF2, and these viral promoters also served as a control for the potential
NF-AT, which were first identified in non-neuronal cells, induction of Gal4-CREB and Gal4-CaRF protein expression during
membrane depolarization. The data presented are the average ofCaRF was cloned from a functional screen for calcium-
at least three measurements from each of three independent experi-dependent transcription factors expressed in neurons.
ments. Statistical significance was determined by ANOVA using theGiven that the regulation of CaRF activity appears to be
Statview program.
selectively induced by calcium influx into neurons, this
factor and others regulated in a similar fashion would
Quantitative RT-PCRnot have been found in studies of non-neuronal cells,
RNA was prepared with the Absolutely RNA kit (Stratagene). Eight
raising the possibility that other important regulators of hundred nanograms RNA was used for reverse transcription with
activity-dependent transcription in neurons may remain the First Strand Superscript II kit (Invitrogen). PCR was carried out
to be discovered. in an iCycler (BioRad) using SYBR-green (P-E Applied Biosystems).
Each independent sample was assayed in triplicate. Threshold cycleSince CaRF is selectively activated by calcium influx
for each sample was taken from the linear range and converted tointo neurons, it is a good candidate for conferring neu-
a starting quantity by interpolation from a standard curve run onron-selective induction upon the expression of neu-
the same plate for each set of primers. BDNF and c-fos levels were
ronally enriched genes required for brain-specific func- normalized for each well to GAPDH. Single PCR products were
tions, such as synaptic transmission. The mechanisms verified both by assessing that the melting temperature of the prod-
that regulate the transcription of synaptically enriched uct had a single value, and by viewing the PCR product on an
agarose gel.gene products remain to be characterized. Once the
consensus binding sequence for CaRF is fully character-
ized, it will be important to search the available genome Nuclear Extracts and Electrophoretic Mobility Shift Assays
Nuclear extracts and EMSAs were done as described (Tao et al.,databases to determine if the promoters of genes such
1998). The CaRE1 probe was synthesized as complementary oligo-as Narp, Homer, and Cpg15 contain the CaRF binding
nucleotide probes 5-GAGTGTCTATTTCGAGGCAGAGGAGG-3 andsite and also to determine if these or other activity-
5-CCTCCTCTGCCTCGA-3. Wild-type and mutant unlabeled probesregulated genes in the brain are selectively induced by
were synthesized by PCR using primers 5-GGTAATTCGTGCAC
calcium and regulated by CaRF. Given that activity- TAG-3 and 5-CGAGAGGGCTCCACGCTGC-3. In competition
dependent gene expression is required for neuronal de- assays, unlabeled probes were added to nuclear extracts in 100-
fold molar excess to the radiolabeled probe for 30’ at 4C prior tovelopment, survival, and long-term changes in synaptic
addition of the labeled probe. In antibody supershift assays, 1 ulefficacy, it may be anticipated that CaRF will also be
anti-CaRF antibody or preimmune serum was added to the nuclearfound to play an important role in these biological pro-




The yeast one-hybrid screen for CaRE1 interaction proteins wasPlasmids
BDNF pIII(170)Luc, EF--gal, pSG424 (Gal4only), Gal4CREB, and carried out using the Matchmaker Yeast one-hybrid system (Clon-
tech). Eight repeats of the CaRE1 sequence (from nucleotides 79Gal4-UAS-Luc were described previously (Abdollah et al., 1997;
Sheng et al., 1991; Tao et al., 1998). We generated 2 bp substitutions to 58) were cloned upstream of the HIS3 gene and four copies
were cloned upstream of LacZ. These plasmids were integrated toof BDNF pIII(170)Luc by PCR with a 5 oligo containing two random
bases at 2 bp intervals from nucleotides 77 to 60 in promoter generate a yeast reporter strain, and the strain was transfected with
a human fetal brain library containing 3.5  106 independent clonesIII. CaRE1-Luc has three copies of the BDNF promoter III sequence
from 79 to 58 upstream of the SV40 minimal promoter in the fused to the transcriptional activation domain of the yeast Gal4
protein (Clontech). Colonies that grew on minimal medium lackingvector pGL3 (Promega). CRE-Luc is from Stratagene and TK-pRL
is from Promega. CaRF and its deletion mutants were cloned into histidine were lifted on filters and screened for -gal expression.
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Library Hybridization and RACE neuronal acetylcholine receptors induces rapid gene transcription.
Science 234, 80–83.Filter lifts of colonies infected with a mouse P0 brain library in lambda
phage (Stratagene) were hybridized with a probe from bases 685 Impey, S., Obrietan, K., Wong, S.T., Poser, S., Yano, S., Wayman,
to 825 of human CaRF. One positive clone was recovered and se- G., Deloulme, J.C., Chan, G., and Storm, D.R. (1998). Cross talk
quenced. 3RACE (Invitrogen) was performed with a polyA anchored between ERK and PKA is required for Ca2 stimulation of CREB-
3 primer, and 5 RACE was performed with the RLM-RACE kit dependent transcription and ERK nuclear translocation. Neuron 21,
(Ambion). 869–883.
Kafitz, K.W., Rose, C.R., Thoenen, H., and Konnerth, A. (1999). Neu-
Antibodies rotrophin-evoked rapid excitation through TrkB receptors. Nature
His-tagged CaRF (amino acids 145–725) in the pET vector (Novagen) 401, 918–921.
was transfected into the BL21 strain of E. coli and expression of Lanahan, A., and Worley, P. (1998). Immediate-early genes and syn-
the protein was induced with IPTG. The protein was purified from aptic function. Neurobiol. Learn. Mem. 70, 37–43.
lysed bacteria over nickel resin (Invitrogen) and isolated by SDS-
Leibrock, J., Lottspeich, F., Hohn, A., Hofer, M., Hengerer, B., Masia-PAGE. Purified protein was injected into rabbits (Covance) and the
kowski, P., Thoenen, H., and Barde, Y.-A. (1989). Molecular cloningserum was collected. Anti-CaRF preimmune and immune serum
and expression of brain-derived neurotrophic factor. Nature 341,was used at 1:1000 for Western blotting and 1:500 for cell staining.
149–152.The mouse TuJ1 anti--tubulin III antibody (Babco) was used at
Liang, F.Q., Walline, R., and Earnest, D.J. (1998). Circadian rhythm1:300, and mouse anti-GFAP (Roche Molecular Biochemicals) was
of brain-derived neurotrophic factor in the rat suprachiasmatic nu-used at 1:250.
cleus. Neurosci. Lett. 242, 89–92.
Lohof, A.M., Ip, N.Y., and Poo, M.-m. (1993). Potentiation of devel-Northern Blotting and In Situ Hybridization
oping neuromuscular synapses by the neurotrophins NT-3 andMouse multiple tissue northern was purchased from Ambion. In
BDNF. Nature 363, 350–353.situ hybridization was performed as described (Corfas et al., 1995).
Frozen sections were cut from paraformaldehyde fixed P4 mouse Mao, Z., Bonni, A., Xia, F., Nadal-Vicens, M., and Greenberg, M.E.
heads or perfused adult brains. An antisense 33P-labeled CaRF probe (1999). Neuronal activity-dependent cell survival mediated by tran-
was made against the complete coding sequence. scription factor MEF2. Science 286, 785–790.
McAllister, A.K., Lo, D.C., and Katz, L.C. (1995). Neurotrophins regu-
late dendritic growth in developing visual cortex. Neuron 15,Acknowledgments
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